论文部分内容阅读
目的探讨非小细胞肺癌患者手术中淋巴结清扫范围的作用。方法选择2008年1月-2010年1月我院手术治疗的ⅢA期非小细胞肺癌患者40例,观察组在给予肺切除的同时行系统纵隔淋巴结清扫术,对照组则在肺切除同时仅行肺门淋巴结清扫术。结果与对照组患者相比,观察组患者术后并发症未见明显增加(P>0.05),观察组患者1、2、3年生存率均高于对照组(P<0.05)。结论系统淋巴结清扫能明显提高ⅢA期非小细胞肺癌患者临床疗效,改善预后。
Objective To investigate the role of lymph node dissection in patients with non-small cell lung cancer. Methods Forty patients with stage ⅢA non-small cell lung cancer undergoing surgery in our hospital from January 2008 to January 2010 were selected. The observation group underwent pneumonectomy with systematic mediastinal lymph node dissection and the control group with lung resection only at the same time Hilar lymph node dissection. Results Compared with the control group, there was no significant increase in postoperative complications in the observation group (P> 0.05). The 1, 2 and 3-year survival rates in the observation group were significantly higher than those in the control group (P <0.05). Conclusion Systemic lymph node dissection can significantly improve the clinical efficacy of patients with stage Ⅲ A non-small cell lung cancer and improve the prognosis.